Skip to the content
halfrx
← Every Rybelsus program

Rybelsus Savings Offer

Novo Nordisk publishes this at as little as $25 for a 1-, 2- or 3-month prescription. Copay card — needs insurance that already covers the drug.

Last updated 2026-09-08 — the last time this offer was read from Novo Nordisk's own page. Read and dated by Alex Seot.

What does the Rybelsus Savings Offer actually get you?

Novo Nordisk publishes the Rybelsus Savings Offer at as little as $25 for a 1-, 2- or 3-month prescription. It is a copay card rather than a price. It lowers what you pay at the counter where a commercial plan already covers the drug, up to a cap on the manufacturer's contribution. With no coverage there is no copay for it to lower. The condition attached: Capped at $100 of savings for a 1-month supply, $200 for two and $300 for three. It cannot be used with Medicare or Medicaid at all: federal anti-kickback rules bar a manufacturer from subsidizing a copay inside a federal program. Who qualifies: Commercially insured patients with coverage for Rybelsus (Novo's wording: "Eligible, commercially insured patients with product coverage only"). A price checked more than 45 days ago is marked stale on this site rather than quietly aging.

The terms, as published

Price
As little as $25 for a 1-, 2- or 3-month prescription
Who for
Commercially insured patients with coverage for Rybelsus (Novo's wording: "Eligible, commercially insured patients with product coverage only").
The catch
Capped at $100 of savings for a 1-month supply, $200 for two and $300 for three — two-thirds of the $150 Lilly allows on its Mounjaro and Trulicity cards, and the same as its Zepbound card, for the same $25 headline. At 7 mg and 14 mg the prescription itself has to be written as a 1-, 2- or 3-month supply to qualify; at 3 mg the offer is $25 a month. No annual ceiling and no fill limit is published on this page, and no end date either, which means the terms can change without one expiring.
Ends
No published end date

If your plan already covers Rybelsus

This is the case the Rybelsus Savings Offer is built for. The plan pays the bulk, the card pays down what is left of the copay up to the sponsor's own cap, and the published figure is what a covered patient sees at the counter. What you pay still counts towards your deductible and out-of-pocket maximum, because it is a copay — that is the structural advantage over any cash price.

If it does not cover Rybelsus

A copay card reduces a copay, and with no coverage there is no copay for the Rybelsus Savings Offer to reduce. Any separate price Novo Nordisk sets for that case is in its own terms, linked above. Getting the plan to cover it is the other route, and it is worth trying before settling for a cash price.

What the card actually caps

Novo Nordisk caps its own contribution at $100 per one-month fill. The advertised figure is what you pay when the plan is already covering the rest; these are the numbers that decide whether it lasts.

Read from rybelsus.com on 2026-09-08. Novo Nordisk states it may change these maximums at its own discretion, with or without notice.

What Rybelsus costs with no program at all

No verified all-in maintenance price is published for Rybelsus, so there is no honest baseline to set this program against — which is itself worth knowing before signing up to it.

Questions about the Rybelsus Savings Offer

How can I get Rybelsus for $25?
$25 is what you pay at the counter once a commercial plan is already covering Rybelsus and the card pays down the copay that remains. It is not a price you can buy at: it needs that coverage, and Novo Nordisk caps its own contribution at $100 a one-month fill. Capped at $100 of savings for a 1-month supply, $200 for two and $300 for three — two-thirds of the $150 Lilly allows on its Mounjaro and Trulicity cards, and the same as its Zepbound card, for the same $25 headline. At 7 mg and 14 mg the prescription itself has to be written as a 1-, 2- or 3-month supply to qualify; at 3 mg the offer is $25 a month. No annual ceiling and no fill limit is published on this page, and no end date either, which means the terms can change without one expiring.
Who qualifies for the Rybelsus Savings Offer?
Commercially insured patients with coverage for Rybelsus (Novo's wording: "Eligible, commercially insured patients with product coverage only"). It cannot be used by anyone on Medicare, Medicaid or any other federal program — federal anti-kickback rules bar a manufacturer from subsidizing a copay inside one. Read from Novo Nordisk's own page on 2026-09-08.
Is there a 2026 Rybelsus Savings Offer?
Yes. Novo Nordisk publishes it with no end date, and the terms above were read from Novo Nordisk's own page on 2026-09-08. No end date is not the same as permanent — an offer withdrawn quietly is exactly what the read date on this page exists to catch.
Do I need insurance to use the Rybelsus Savings Offer?
Yes — commercial insurance. The $25 is a copay the card pays down, so it needs a plan that already covers Rybelsus; where the plan covers nothing there is no copay to reduce. It cannot be used by anyone on Medicare, Medicaid or any other federal program.
What is the catch on the Rybelsus Savings Offer?
Capped at $100 of savings for a 1-month supply, $200 for two and $300 for three — two-thirds of the $150 Lilly allows on its Mounjaro and Trulicity cards, and the same as its Zepbound card, for the same $25 headline. At 7 mg and 14 mg the prescription itself has to be written as a 1-, 2- or 3-month supply to qualify; at 3 mg the offer is $25 a month. No annual ceiling and no fill limit is published on this page, and no end date either, which means the terms can change without one expiring.
When does the Rybelsus Savings Offer end?
No end date is published. That is not the same as permanent — an offer withdrawn quietly is the failure mode this page exists to catch, which is why the date it was last read sits beside every figure.

halfrx is not affiliated with Novo Nordisk and is paid nothing for listing this. Every figure is read from Novo Nordisk's own page on the date shown. Information only, not medical advice.

Why this program excludes who it excludes

The condition on this card is not the maker's preference. These are the documents behind who is shut out of it.

Everything on Rybelsus

Something on this page wrong? Tell us

Please leave out anything about your own health. How a report is handled: privacy.